Teva Pharma (TEVA) on Watch Amid Unconfirmed Takeover Chatter
- Nasdaq hits record; bank earnings validate Wall St. rally
- Intrawest Resorts (SNOW) Exploring a Possible Sale - Reuters
- Alibaba (BABA) Has No Plans to Acquire Rest of Groupon (GRPN) - Source
- Time (TIME) Said to Soon Begin Discussions with Interested Buyers - Bloomberg
- JPMorgan (JPM) Reports Q4 EPS of $1.71
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Teva Pharma (NYSE: TEVA) on Watch Amid Unconfirmed Takeover Chatter
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rubicon Project (RUBI) to Explore Strategic Options, Including Sale - DJ
- Teva Announces Completion of Sale of UK and Ireland Actavis Assets and Operations Following European Commission Approval
- Stocks with call price movement; USO AMZN
Create E-mail Alert Related CategoriesRumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!